Vertex Perspectives | Global Innovation and Venture Capital Beyond the Pandemic - Highlights

Vertex Partnership Group posted on 16 Jun 2020

Vertex Holdings recently hosted a webinar with its global partners to discuss how COVID-19 will impact global technology trends and venture capital activities. The discussion covered a few broad topics:

  • The recovery outlook across different markets
  • Structural changes with the acceleration of consumer activities online
  • Investment strategies over the next 12 months

Here are some highlights of the webinar:



In this first video, our panelists discusses the near-term COVID-19 recovery outlook.



Carolyn NG of Vertex Ventures HC shares her views on the recovery outlook from a healthcare and biopharma perspective.



What are the longer term, structural changes that could come out of this? Our panelists discuss how our portfolio companies are navigating this changing landscape.



In this final video, our partners share how they are looking at investing and managing their portfolios over the next 12 months, and address some burning questions from our webinar audience.




If you would like to view the full webinar video, sign up for access here.

If you would like to read the full webinar transcript, sign up for access here.
Copied

Recent posts

Technopreneur Webinar Series 2020

ImgVertex Holdings is pleased to present an 11-Part Technopreneur Webinar Series. This series aims to facilitate the sharing and exchange of ideas and insights, as well as provide fundamental understanding of the intricacies of entrepreneurship for aspiring technology founders and innovators.

16 Jun 2020
Read more

Vertex Ventures HC | Elevation Oncology Emerges from Stealth

Elevation Oncology, a clinical stage biopharmaceutical company focused on the development of precision medicines for patients with genomically defined cancers, announced today the launch of the Company with a $32.5M Series A financing, to explore innovative models for real-time identification, patient referral, and enrollment of patients with tumors driven by rare genomic alterations. The Series A financing was led by Aisling Capital and a syndicate of investors including Vertex Ventures HC, Qiming Venture Partners USA, Driehaus Capital Management, and BVF Partners.

16 Jun 2020
Read more

Vertex Growth | Investment in Taranis' USD 30M Series C round

TARANIS, an ag-tech startup that uses aerial surveillance and machine learning to help prevent crop-yield loss, said on Wednesday that it has raised US$30 million in a Series C round led by Vertex Growth and Kuok Group’s Orion Fund (managed by K3 Ventures).
Tam Hock Chuan, managing director of Vertex Growth said: “The adoption of Taranis’ solutions will help growers and crop consultants to detect, analyse and treat crop issues at their earliest signs, taking preventive measures with unprecedented precision. This will give them a higher degree of control over their crop yield than ever before, particularly relevant in Asia where the agriculture sector has a relatively lower yield per hectare compared to global benchmarks.”

16 Jun 2020
Read more

Quick Links

Our Global Network

The Vertex global network of venture capital funds comprises Vertex Ventures, Vertex Ventures HC and Vertex Growth.

With funds based across innovation hubs in China, Israel, Southeast Asia and India, and the US, we create a unique platform for portfolio companies to realize their full potential by leveraging the combined experience and resources of our extensive network of global partners.

Copyright

© 2019 by Vertex Holdings. All rights reserved. Legal


Advisory on Hiring Scams

We are aware of scammers using social media, email, SMS and/or other channels impersonating Vertex staff offering employment opportunities at Vertex. Please ignore such unsolicited calls, text messages and discard such emails. Do not respond nor provide any personal information. If you require any clarification, please contact us.